for the BOTA shareprice!
Went off like a party popper since the Nasdaq struck 2014.
Looks a little more solid than previous efforts, so lets see what the rest of the year brings. Flu activity, especially H1N1, is early and reasonably active. Hopefully, this translates to a high chance of trial completion on schedule.
No comments:
Post a Comment